Brian Hilbush
Overview
Explore the profile of Brian Hilbush including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michail S, Lin M, Frey M, Fanter R, Paliy O, Hilbush B, et al.
FEMS Microbiol Ecol
. 2015 Mar;
91(2):1-9.
PMID: 25764541
Obesity is becoming the new pediatric epidemic. Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity and has become the most common cause of pediatric liver disease. The gut...
2.
Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, et al.
Nat Biotechnol
. 2011 Dec;
30(1):61-8.
PMID: 22178994
Distinguishing single-nucleotide variants (SNVs) from errors in whole-genome sequences remains challenging. Here we describe a set of filters, together with a freely accessible software tool, that selectively reduce error rates...
3.
Lo D, Hilbush B, OMahony D, Sutcliffe J
Expert Rev Vaccines
. 2003 Aug;
1(1):95-100.
PMID: 12908516
Ongoing development of vaccines is limited by the techniques used to identify routes to immunization. Using open system gene expression profiling, researchers can now directly identify receptors used by M-cells...
4.
Wieland S, Vega R, Muller R, Evans C, Hilbush B, Guidotti L, et al.
J Virol
. 2002 Dec;
77(2):1227-36.
PMID: 12502840
We have previously shown that alpha/beta interferon (IFN-alpha/beta) and IFN-gamma inhibit hepatitis B virus (HBV) replication noncytopathically in the livers of HBV transgenic mice and in hepatocyte cell lines derived...
5.
Lo D, Hilbush B, Mah S, Brayden D, Byrne D, Higgins L, et al.
Adv Drug Deliv Rev
. 2002 Oct;
54(9):1213-23.
PMID: 12393302
Drug delivery technologies are commonly directed towards formulations to control the delivery of therapeutic compounds. However, many processes in the human body have evolved to regulate the transport of various...